Dr. Wambui Machua, MD

Dr. Machua practices at Piedmont Hospital, Inc - HOPD in Atlanta, Georgia.

Dr. Machua's NPI, 1144541079, was assigned on June 15, 2010. Dr. Machua holds Georgia license 069892.

Dr. Machua's primary practice is Piedmont Hospital, Inc - HOPD, at 1800 Howell Mill Road, Atlanta, GA 30318.

Dr. Machua's primary practice is Piedmont Hospital, Inc - HOPD in Atlanta, Georgia. Dr. Machua is also affiliated with Piedmont Atlanta. The medical group on file is Piedmont Physicians Obstetrics and Gynecology of Jasper. Dmand AI also links Dr. Machua to 1 more hospital, 1 breast imaging center and 1 group practice or clinic, each named with a free account. Dr. Machua's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Machua practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Machua's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Machua is licensed in Georgia.

CMS data shows 1,496 Medicare services from Dr. Machua across 5 procedure codes in 2024, for 106 Medicare patients. Medicare paid $41,262 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Dr. Machua in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 71% have arthritis. 12% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Machua's median patient age at 55, with 86% women.

In 2024, Dr. Machua wrote 812 Medicare Part D claims for 177 patients. 80% of them were for generic drugs. CMS names the drug for 675 of them, across 15 drugs with 11 or more claims each, at $404,746 in total drug cost. In 2023, CMS named 548 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Machua for performance year 2024, reported through an alternative payment model (APM). Dr. Machua accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Machua as offering telehealth.

Dmand AI links 5 papers to Dr. Machua, published from 2016 to 2024. The most frequent topics are Lupus Erythematosus, Systemic. Dr. Machua's most frequent co-authors are Alyce M. Oliver, MD, PhD, Anca D. Askanase, MD and Tundun Oreoluwa Babalola, MD.

Dmand AI links Dr. Machua to 6 clinical trials, 4 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Lupus Erythematosus, Systemic. GlaxoSmithKline sponsors the most, 4. Open Payments lists research payments to Dr. Machua that name 1 trial.

CMS Open Payments shows 509 general payments to Dr. Machua from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. GlaxoSmithKline, LLC. paid the most, $7,058. It also lists 13 research payments totaling $1,948 from 2019 to 2020, naming 1 clinical trial.